Timothy J.Heverin (Tim)

Partner

(T) 1.312.269.4087

For 20 years Tim Heverin has represented clients in high-value patent and trade secret disputes, often involving international actors, activity, and witnesses. In doing so he has appeared before district courts across the country, the Federal Circuit, the ITC, and PTAB.

In particular Tim has extensive experience litigating life science patent disputes. He has represented clients in matters concerning pharmaceutical and biologic products such as Prezista®, Hytrin®, Tricor®, Istodax®, and Kuvan®. He recently was part of the team that successfully defeated an institution of four IPRs and defended a separate interference action related to formulation patents for top-selling drug, Humira®.

In addition to his pharmaceutical work Tim has handled patent disputes relating to medical devices, chemical processing, semiconductor fabrication and function, microchip architecture, information theory and coding, and search and database mining.

Tim serves as the Hiring Partner for the Chicago Office, where he heads the office's Recruiting Committee, and as co-chair of the Firm's IP Recruiting and Associate Development Committee. He also serves on the board of directors of the Lawyers' Committee for Better Housing.

Prior to attending law school Tim worked in the U.S. Naval Nuclear Propulsion Program as a nuclear plant engineer at Knolls Atomic Power Laboratory's Kesselring site, where, among other things, he instructed Naval officers in nuclear plant operation and casualty response.

Experience

  • Freescale defends against patent infringement action related to methods of wireless data transmissionJones Day defended Freescale Semiconductor, Inc. in a patent suit alleging infringement of five patents relating to interfaces for serially transmitting or receiving data, acquiring a GPS signal using data bit information, detecting jamming signals in wireless communication devices, and testing responses of radio transceivers.
  • Celgene files declaratory judgment action against CyclacelJones Day represents plaintiff Celgene Corporation in a declaratory judgment action for non-infringement and invalidity of four Cyclacel Pharmaceuticals, Inc. patents related to certain depsipeptides and uses thereof.
  • Abbott prevails in patent infringement action against SandozJones Day represented Abbott Laboratories ("Abbott") in a patent infringement action brought under the Hatch-Waxman Act in the United States District Court for the District of Delaware against Sandoz, Inc.
  • Freescale and Interphase defend against patent infringement allegations over semiconductor technologyJones Day defended Freescale Semiconductor, Inc. and Interphase Corporation against allegations of infringing eight patents relating to various aspects of semiconductor technology.
  • IBM defends against patent infringement charges relating to data management on computer networksJones Day represented defendant IBM in a patent infringement case relating to management of data caching on computer networks.
  • IBM settles patent infringement case against Amazon.com involving data storage and presentationJones Day represented International Business Machines Corporation ("IBM") in a patent infringement case against Amazon.com.
  • PCS settles patent infringement suit after favorable Markman rulingJones Day represented Potash Corporation of Saskatchewan, Inc. and obtained a favorable settlement in a patent licensing dispute concerning chemical processing technologies.
  • IBM settles patent infringement case against Amazon.com involving electronic ordering systemsJones Day represented IBM in a patent infringement case against Amazon.com.
  • Micron Technology resolves patent infringement suit over semiconductor packaging for DRAMsJones Day represented plaintiff Micron Technology in a patent infringement / antitrust litigation involving semiconductor packaging for DRAMs.
  • IBM defends against patent infringement charges over detectors for defective floppy diskette controllersJones Day defended IBM in a patent litigation relating to systems and methods for detecting defective floppy diskette controllers.
  • IBM defends against patent infringement claims concerning electronic credit card transactionsJones Day represented IBM in defending against claims of infringement of several patents directed to the processing of credit card transactions over the internet.
  • Abbott pursues patent infringement and related litigation involving HYTRIN®Jones Day represented Abbott Laboratories in various federal court proceedings asserting Hatch-Waxman patent infringement claims against several generic manufacturers seeking FDA approval to market a version of Abbott's HYTRIN® product and in related tort claims brought against Abbott by a generic manufacturer in the context of Abbott's defense of its patents.
  • Abbott pursues several Hatch-Waxman patent infringement cases over blood pressure drug TRICOR®On behalf of Abbott Laboratories, Jones Day prosecuted several Hatch-Waxman patent infringement cases against generic manufacturers seeking FDA approval to market a version of Abbott's drug TRICOR®, which is used to treat high blood pressure.
  • Simmons defends against patent and trademark infringement charges brought by rival SertaJones Day defended Simmons Company against bedding rival Serta, Inc. and its U.S. licensees in an action involving allegations of patent infringement, common law trademark infringement, and related claims.
  • Motorola and Freescale resolve patent suit with STMicroelectronics over 12 semiconductor patentsJones Day obtained a settlement for Motorola and Freescale in two patent infringement lawsuits involving 12 semiconductor product, packaging, and process patents.
  • Motorola and Freescale resolve patent infringement suit brought by Analog Devices involving microchip fabricationJones Day represented Motorola and Freescale in a patent infringement lawsuit involving 11 semiconductor product, packaging and process patents covering microchip fabrication and circuitry technology.
  • Eastman Chemical wins dismissal in infringement action over patent for equipment computer software controlJones Day assisted Eastman Chemical Company in connection with an infringement action on a patent for equipment computer software control.
  • Eastman Kodak settles patent infringement case involving online image storage technology and data management systemsJones Day represented Eastman Kodak Company and its subsidiary Ofoto in a patent infringement case against on-line photosharing and photofinishing websites involving patents relating to data management, order delivery systems, uploading, storing, and printing of digital images using the Ofoto.com web site.
  • Additional Publications

    • May 2018Additional Discovery: Must Be More Than Mere Possibility, PTAB Litigation Blog
    • April 2018It’s Obvious: POSA Could Write Software To Generate Conference Call Requests, PTAB Litigation Blog
    • December 2017Federal Circuit Rules BPCIA Preempts State Law
    • June 2017Supreme Court: Biosimilar Applicants May Provide Commercial Marketing Notice Before FDA Approval
    • July 2016180-Day Notice of Commercial Marketing Mandatory Even When Biosimilar Applicants Do the "Patent Dance"
    • March 2016New Amgen Complaint Seeks Declaration Regarding Participation in the BPCIA's "Patent Dance"
    • March 2016New BPCIA Complaint Alleges that Proposed Biosimilar Version of Enbrel® Infringes Five Patents
    • December 2015Southern District of Florida Rules that 180-Day Notice of Commercial Marketing Is Mandatory When Parties "Patent Dance"
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.